Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Denbri Injection

Prescription Icon
Prescription Required

Marketer

RPG Life Sciences Ltd

Salt Composition

Denosumab (60mg/ml)

Overview Denbri Injection

OsteoPro Injection treats osteoporosis in postmenopausal women and fracture-prone men, strengthening bones and lowering fracture risk. Administered by a healthcare provider, it requires consistent daily use for optimal results. Complete the prescribed course, even with symptom improvement. Calcium and vitamin D supplementation enhances its efficacy. Common side effects may include headache, limb pain, musculoskeletal discomfort, neuropathy, constipation, and skin rash. Persistent or worsening side effects warrant medical attention; your doctor can offer management strategies. Prior to treatment, inform your doctor of all other medications. Pregnant or breastfeeding individuals should consult their doctor before using OsteoPro Injection.

Uses of Denbri Injection

Bone fragility

Major Benefits of Denbri Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Denbri Injection:

  • Musculoskeletal (bone, muscle or joint) pain
  • Pain in extremities
  • Nerve pain
  • Constipation
  • Rash
  • Headache

How to use Denbri Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Denbri Injection works:

Denbri Injection, a monoclonal antibody therapy, targets a protein responsible for bone degradation, promoting bone health and reducing fracture risk.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Denbri Injection concurrently with alcohol. Physician consultation is recommended.

PregnancyPregnancyUNSAFE

Administering Denbri Injection during pregnancy carries substantial risks. Pregnant individuals should consult their physician; research in animal and human studies reveals considerable harm to the fetus.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Denbri Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential drug transfer via breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Denbri Injection.

KidneyKidneyCAUTION

Caution is advised when administering Denbri Injection to individuals with significantly impaired renal function. Dosage modification for Denbri Injection may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with severe hepatic impairment should receive Denbri Injection with careful monitoring. Dosage modification for Denbri Injection may be necessary. Physician consultation is advised.

What if you forget to take Denbri Injection :

Should you forget a Denbri Injection dose, contact your physician for guidance.

Facts to Know About Denbri Injection

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Treatment Category Pain Relievers

FAQs on Denbri Injection

Optimal Denbri Injection treatment duration for osteoporosis isn't established. Treatment length depends on individual patient response and tolerability, closely monitored through regular assessments, particularly after five years of use.
Hair loss is a possible side effect of Denbri Injection, though not everyone experiences it. Talk to your doctor if you're concerned about hair loss.
Denbri Injection, a monoclonal antibody protein, doesn't employ chemotherapy. It works by targeting a specific protein to treat bone loss and osteoporosis, thereby strengthening bones and reducing fracture risk.
Denbri Injection is administered by a healthcare professional every six months. Your doctor might also recommend calcium and vitamin D supplementation.
Pregnant women must not receive Denbri Injection. Effective contraception is required during and for five months following the final Denbri Injection dose for women of childbearing potential.
Store Denbri Injection in its original carton in a refrigerator at 2°C to 8°C (36°F to 46°F). Heat reduces its effectiveness; therefore, correct storage is crucial. Once removed, keep it at room temperature (up to 25°C/77°F) in the original carton and use within 14 days.
Jaw bone damage (osteonecrosis) is a rare complication of Denbri Injection. Maintain good oral hygiene and regular dental checkups while using Denbri. Report any mouth or teeth problems—loose teeth, discharge, pain, swelling, or non-healing sores—to your doctor and dentist immediately, as these may indicate osteonecrosis.
Denbri Injection
20,304
MRP 23,500
13% off